FOUZIA KHAN

Concepts (56)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vagina
2
2024
208
0.930
Why?
Premature Birth
2
2024
428
0.770
Why?
Microbiota
2
2024
438
0.720
Why?
HIV Infections
1
2024
2049
0.360
Why?
Irritants
1
2025
8
0.220
Why?
Urinary Bladder, Overactive
1
2025
30
0.210
Why?
Pharmacology
1
2023
6
0.200
Why?
Placenta
1
2024
504
0.150
Why?
Pregnancy Complications, Infectious
1
2024
514
0.150
Why?
Curriculum
1
2023
798
0.130
Why?
Gastrointestinal Microbiome
1
2024
842
0.120
Why?
Cell- and Tissue-Based Therapy
1
2017
151
0.110
Why?
Lansoprazole
1
2015
39
0.110
Why?
Pregnancy
2
2024
7512
0.110
Why?
Upper Extremity
1
2015
53
0.110
Why?
Vasodilation
1
2015
175
0.100
Why?
Peripheral Arterial Disease
1
2017
326
0.090
Why?
Proton Pump Inhibitors
1
2015
326
0.090
Why?
Coronary Disease
1
2015
624
0.090
Why?
Female
5
2025
70963
0.060
Why?
Chocolate
1
2025
2
0.060
Why?
Citrus
1
2025
5
0.060
Why?
Sweetening Agents
1
2025
37
0.050
Why?
Lactobacillus
1
2024
41
0.050
Why?
Mouth
1
2024
68
0.050
Why?
Humans
6
2025
131163
0.050
Why?
Aldehyde Dehydrogenase
1
2017
41
0.030
Why?
Intermittent Claudication
1
2017
48
0.030
Why?
Extremities
1
2017
73
0.030
Why?
Perfusion
1
2017
209
0.030
Why?
Bone Marrow Cells
1
2017
243
0.030
Why?
California
1
2015
127
0.030
Why?
Cross-Over Studies
1
2015
258
0.030
Why?
Bone Marrow Transplantation
1
2017
589
0.030
Why?
Drug Administration Schedule
1
2015
732
0.020
Why?
Administration, Oral
1
2015
711
0.020
Why?
Arginine
1
2015
340
0.020
Why?
Comorbidity
1
2017
1595
0.020
Why?
Infant, Newborn
1
2024
8635
0.020
Why?
Pilot Projects
1
2015
1445
0.020
Why?
Exercise
1
2017
892
0.020
Why?
Predictive Value of Tests
1
2015
2304
0.020
Why?
Reproducibility of Results
1
2015
2904
0.020
Why?
Follow-Up Studies
1
2017
5196
0.020
Why?
Quality of Life
1
2017
2082
0.020
Why?
Middle Aged
2
2017
28601
0.010
Why?
Risk Assessment
1
2015
3711
0.010
Why?
Biomarkers
1
2015
3385
0.010
Why?
Time Factors
1
2015
6196
0.010
Why?
Prospective Studies
1
2015
6459
0.010
Why?
Risk Factors
1
2017
11074
0.010
Why?
Treatment Outcome
1
2017
12936
0.010
Why?
Young Adult
1
2015
10103
0.010
Why?
Male
2
2017
64957
0.010
Why?
Aged
1
2017
21025
0.010
Why?
Adult
1
2015
31282
0.010
Why?
KHAN's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (56)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_